Diabeloop at CES in Las Vegas from January 8 to 11: its groundbreaking innovation
Paris, December 17, 2018 – Making its second appearance at CES, the world’s leading technology event, on January 8-11, 2019 at Las Vegas, the Grenoble-based firm, Diabeloop, invited by the CEA,
will present its plan to adapt its machine-learning adult diabetes management system to children.
At CEA Tech Village in Eureka Park, Sands Expo
A pioneering system born from cutting-edge R&D serving Type 1 diabetes patients
Since 2015 Diabeloop and its R&D partner, CEA-Leti, have striven to transform the lives of people with Type 1 diabetes and their loved ones.The solution developed by Diabeloop is an integrated closed-loop insulin delivery system made up of three devices:
a continuous glucose monitor (CGM), a patch insulin pump and a handset terminal hosting the algorithms developed by Diabeloop and acting as a user interface with the system.
These algorithms predict blood sugar levels and instruct the pump to automatically deliver insulin doses.
The result of extensive consultations with patients, doctors, engineers and software developers, this disruptive innovation will transform the lives of patients, relieving them of many of the daily treatment decisions they have to make.
Clinical trials with children are set to begin in Belgium and France in 2019.
New financing round
In November 2018 Diabeloop launched a second round of financing to support its ambitious R&D objectives and the international rollout of its DBLG1 system for adults.
Founded in 2015 in Grenoble by Erik Huneker and Dr Charpentier.Diabeloop and CEA-Leti work together at a shared research laboratory to speed up the development of the system. Marc Julien and Erik Huneker are the firm’s joint CEOs.
Financed via €13.5 million raised in equity and debt in Jun-Aug 2017 with a second round of financing currently under way.